VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus. The company’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. The company’s second platform is a thermostable technology that enables the…
Neuronasal develops drugs, delivered intranasally, for acute brain injuries. Our first products are for concussion. Neuronasal was founded to create value for patients and investors by licensing and developing drugs to treat acute brain injuries and disease. We plan to develop each of our drugs to proof of concept and then enter into strategic partnerships or trade sales. Neuronasal’s first two products are repurposed off patent drugs, deferoxamine and N acetyl cysteine, that we will deliver with existing intranasal delivery devices in clinical trials for concussion and intracerebral…
We are engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Controlled-release means releasing a drug into the bloodstream or at a target site in the body, over an extended period of time or at predetermined times. In some circumstances, controlled-release drug delivery can enhance efficacy and patient compliance as compared to immediate release formats for the same drug.Our proprietary Hypermatrix™ technology is at the core of our controlled-release drug delivery approach. The flexibility of the Hypermatrix™ technology…
MediNatura is dedicated to manufacturing and distributing high quality, FDA regulated products. We know people can improve their lives by making healthy lifestyle choices, healthy food choices and healthy medicine choices. MediNatura's mission is to improve lives with medicines from nature.
Alba Biologics Group is a leading biopharmaceutical strategic and technical support group providing consulting and management services to start-ups, early product developers and established industry leaders. With 20 years experience Alba Biologics leverages the expertise of the founder and our associates to help clients advance drug candidates from the bench through to regulatory approval. Alba will support client organizations on both short and long term projects working with a clientпїЅs in house staff as well as integrating with contract service providers.Alba Biologics brings to the…
Barnes Healthcare Services was founded in 1909 by Charles W. Barnes, Rph. in a corner drug store in Valdosta, Georgia. In those days medications were compounded by hand and the horse was the main mode of transportation. In 1946 Barnes supplied its first patient with a hospital bed, oxygen and a wheelchair. The business has been passed down through three generations to Charles W. Barnes, III whose vision, dedication to the patient, and desire to be the best provider in the area has grown the business to 21 locations in Georgia, Florida, and Alabama.
Alpha Cancer Technologies Inc., (ACT) is a private clinical stage biotechnology company with products under development in oncology and auto-immune disease indications. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP) with unique immuno-oncology properties.One of the largest US biotech companies recently purchased a 14% equity stake in ACT for US $7.5 million as part of a larger financing with institutional and private investors.
QUADRAS is a global provider of unique, enterprise-class Data Collection and Professional Service solutions, with a specialization in mobile data capture and RFID technologies. Our business solutions are focused on optimizing operations, reducing expenses, and improving business processes, and they have successfully been applied across a wide range of industries.As recognized leaders in the Data Collection, RFID, and EAM/IT Consulting fields, we stand behind our know-how, our recommendations, and our implementations - we will execute what we promise and help you attain your key performance…
The biggest unmet medical need is to provide safe and efficacious drugs to the patient. However, the pharmaceutical industry is currently facing a litany of challenges, including but not limited to: 1) lead identification; 2) lead optimization & prioritization; 3) predicting side effects and toxicity; 4) meeting efficacy requirements; 5) maximizing patent life on the market; and 6) product rescue/repositioning. As a result, R&D success rates are falling, and R&D spending is not contributing to increased sales. According to research by Jack Scannell published in Nature, “...the number of new…
Auritec Pharmaceuticals, Inc. is a research and development (R&D) company, specializing in innovative, extended release drug delivery systems. Auritec was founded by Thomas J. Smith, MD. Dr. Smith was previously Medical Director and Chairman at Control Delivery Systems, Inc. (CDS), where he was the co-founder and PI on key patents. CDS, now Psivida Inc. (NASDQ - PSDV), is a successful device company specializing in ophthalmic extended release therapies. Dr. Smith is joined on Auritec's management team by Gary Ransom, a seasoned international business executive, who focuses on strategy,…
ProNAi Therapeutics is a drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology drug development company oriented towards registration and commercialization. We have a world-class management team with a proven track record of success in oncology drug development and we intend to build a broad and diverse pipeline of promising oncology assets against emerging targets on the leading edge of cancer biology.
Creabilis is a clinical-stage, specialty pharmaceutical company focusing on the development of innovative, first-in-class topical treatments in the field of dermatology. The Company’s lead product, CT327, is a Phase III-ready topical treatment for chronic pruritus (itch), which the Company believes is the most advanced, novel, topical treatment in development for the indication. Pruritus is a debilitating symptom of many dermatological diseases, with a significant negative impact on a patient’s quality of life.
Established in 2004, ConvenePro is a privately held small business specializing in the delivery of highly regulated and innovative programming in the life sciences. We partner with public and private clients, including Fortune 500 companies, to plan and execute results-proven and industry compliant programs to leverage their message.We oversee end-to-end program logistics using specially designed proprietary processes and methods. Our depth and breadth of knowledge of federally mandated compliance, long history of providing superior customer service and effective and timely communication…
Volant Pharma endeavors to innovate and develop new treatments for metabolic diseases such as NASH and Diabetes.Type 2 DiabetesNon-Alcoholic Steatohepatitis (NASH)Weight loss
Ondine Biomedical, Inc. is dedicated to the development of non antibiotic, anti infective therapies for a broad spectrum of bacterial, viral and fungal infections. We are focused on the development and commercialization of our patented light activated technology, photodisinfection. Photodisinfection provides rapid anti microbial efficacy without encouraging the formation and spread of antibiotic resistance.
Techsol Corporation is a leading global technology service organization, providing pharmaceutical industry focused services in the areas of Medical Information, Drug Safety, Signal Detection and Management, Clinical Development and Pharmaceutical Sales Management. Techsol’ global pharmaceutical – information technology focus and techno-functional expertise enables it to provide technology services and consultancy across the drug life cycle.Partnering with pharmaceutical companies, Techsol helps you adopt digital technology to achieve patient safety and regulatory compliance. Techsol…
GCE Solutions founded in 2006 is a CRO serving in the biometrics function. We cater to the need of clients in pharmaceutical, biotechnology and medical device industries on various stages, diverse therapeutic areas, and different aspects of clinical trials. At GCE, we believe in a strong foundation and the four pillars of our organization are our smart motivated Professionals, our Innovative approach, our comprehensive Solutions and reliable Services. With GCE Solutions’ proven capabilities and strong credentials, we have many highly satisfied customers and more than 90% repeat business.…
Alternative Laboratories is a leading provider to the direct sales and nutrition industry specializing in providing companies with a diverse portfolio of patented, scientifcally validated, nutraceutical ingredients and products. From formulation to manufacturing, we are your convenient and trusted partners. We employ highly skilled laboratory scientists and formulators with over 50 years experience, to provide you with in depth research and development, quality control testing, and product analysis to ensure that you receive the highest quality products. Our highly efficient, streamlined…
HR Performance Solutions is a growing software-as-a-service company focused on HR technology. The primary areas of focus include 1) performance management, 2) salary administration, and 3) learning management.
